{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiedkyjtohdzchl3gk3j5hp4zk3ty4rsvvohzilk665vlqvmbwenka",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mng5t4teein2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreib7lbxizh3mnbucj7ctw2zozfmnkwlzvo6wacm3lwljlfywjpw444"
    },
    "mimeType": "image/jpeg",
    "size": 801356
  },
  "path": "/news/2026-06-semaglutide-linked-quality-life-diabetes.html",
  "publishedAt": "2026-06-03T18:10:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "New findings from the landmark FLOW trial, presented at the 63rd ERA Congress, show that once-weekly semaglutide significantly improved health-related quality of life in adults with type 2 diabetes and chronic kidney disease, equivalent to around eight additional days in full health per year.",
  "title": "Semaglutide linked to better quality of life in diabetes and kidney disease, trial shows"
}